Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Viking

IBD Stock Of The Day Novo Nordisk: Why A Pullback Is Bullish For The Weight-Loss Kingpin

The company leads the weight-loss drugs market with its blockbuster, Wegovy. But next-generation drugs are coming.

Investors Business Daily

IBD Stock Of The Day Eli Lilly Jumps Early Entry As Viking Charges Obesity Space

Eli Lilly stock is Wednesday's IBD Stock Of The Day. Shares are forming a flat base as competition mounts for its weight-loss drug, Zepbound.

Investors Business Daily

Viking Surges After Weight-Loss Pill — A Rival To Novo, Lilly — Beats Expectations In Just 28 Days

Viking stock gapped up Tuesday after the biotech company's oral weight-loss drug beat expectations in a 28-day study.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Barbra Streisand Condemns Award Recipients Chosen For Leadership Honor

Barbra Streisand and Ruth Bader Ginsburg's family criticize the decision to award the Leadership Award to Elon Musk, Rupert Murdoch, and others, previously...

Top News

Inside Kirk Cousins’s Departure from Minnesota and His Arrival in Atlanta

The former Vikings quarterback loves road trips, and his journey, along with his agent and family, took 25 months before he finally locked down the guarantees he needed to continue his NFL future with the Falcons.

Sports Illustrated

Up 283% YTD, Is It Too Late to Buy Viking Therapeutics Stock?

Shares of Viking Therapeutics have been on an absolute tear in 2024, as the biotech stock gears up to enter the weight-loss drug market.

Barchart

4 players Minnesota Vikings should let walk in free agency

The Minnesota Vikings are set to have 28 free agents this period. Our staff highlighted four players that shouldn't return to Minnesota.

USA Today Sports Media Group

Read news from The Economist, FT, and more,
with one subscription

Stock Market Rally At Highs After Big Earnings, Inflation Data: Weekly Review

The stock market is right at record highs amid big earnings movers and economic data that didn't spook bond markets.

Investors Business Daily

Viking Therapeutics Catapults 121% As Weight-Loss Drug Beats Out Lilly's Zepbound

A weight-loss drug from Viking topped Lilly's Zepbound in a midstage study Tuesday. Viking stock more than doubled, while Lilly shares fell.

Investors Business Daily

Weight-Loss Tizzy: Why Altimmune Surged 23% As Others Tumbled On A New Study

Biotech stocks Madrigal and Altimmune diverged Monday as Wall Street debated the outcome of a weight-loss study in MASH patients.

Investors Business Daily

Barbra Streisand Receives Emotional SAG Life Achievement Award Speech

Barbra Streisand receives SAG Life Achievement Award in 2024, delivering a heartfelt speech on her illustrious career and the power of storytelling in film.

Top News

Barbra Streisand Honored With Lifetime Achievement Award At SAG

Barbra Streisand, Hollywood legend, honored with Lifetime Achievement Award at SAG Awards for her versatile career and philanthropic contributions.

Top News

Barbra Streisand To Receive Life Achievement Award At Sags

Explore the illustrious career of Barbra Streisand, from her Broadway debut to her iconic roles in film and television, culminating in her status as an EGO...

Top News

Richard Osman to publish first novel in new crime series

We Solve Murders introduces a new detective duo – but the author has not abandoned his Thursday Murder Club characters

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

USA Today Sports Media Group

6 Wide receivers Minnesota Vikings could target in free agency

With both K.J. Osborn and Brandon Powell set to hit free agency, will the Vikings look to replace them? Here's six free agent possibilities.

Investors Business Daily

Viking Therapeutics Charges To A Record High On An Update For Its Eli Lilly-Rivaling Obesity Drug

Viking Therapeutics moved up its timeline for an Eli Lilly-rivaling obesity treatment on Thursday, leading VKTX stock to a record high.

Top News

Dr. Anthony Fauci's Memoir Chronicles Career and Public Health Challenges

Dr. Anthony Fauci, renowned infectious disease expert, is set to release his memoir On Call: A Doctor's Journey in Public Service in June, chronicling his ...

USA Today Sports Media Group

Harrison Phillips named finalist for Alan Page Community Award by NFLPA

The NFLPA announced Thursday evening that Minnesota Vikings DT Harrison Phillips was named as a finalist for the Alan Page Community Award.

Get all your
news in one place.

100’s of premium titles.
One news app.

USA Today Sports Media Group

Vikings get much-needed secondary help in latest mock draft

The Vikings secure much-needed help in the defensive secondary in the latest mock draft.

Top News

Lions Win Season Finale, Await LaPorta's Injury Update for Playoffs

Lions close out regular season with a win over Vikings, but concerns arise over rookie tight end's injury. Playoffs loom for Detroit. Exciting times ahead!

USA Today Sports Media Group

Dalton Risner continues to rise to the occasion

Dalton Risner continues to shine as a Minnesota Viking

USA Today Sports Media Group

4 Vikings make Pro Football Focus’ top 100 free agents list

The Vikings will have some sought after free agents this offseason

USA Today Sports Media Group

Packers’ ability to limit Justin Jefferson started with pressure from pass rush

The Packers kept Vikings QBs under constant pressure and limited Justin Jefferson's impact on Sunday night.

USA Today Sports Media Group

Vikings vs. Lions: 4 offensive keys in week 16

These keys are pivotal for the Vikings offense to succeed and get the win over the Lions

USA Today Sports Media Group

Zulgad: Vikings need to hope Kevin O’Connell learns from a rough day at the office

Judd Zulgad discusses Kevin O'Connell's rough performance and how the Vikings need him to learn from it

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.